NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
+ Phase 3 data due June 2020 -> Signal for the Bull.
评论:
+ Reset near $533.64 and long target will be $605.88 (ATH)
+ Just my idea, use as reference. Not an advice
评论:
Hit $533.64, will hold support. Looking for further movement. Congrats whoever follow the plan
评论:
Hell yeah my baby
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。